478 related articles for article (PubMed ID: 19728332)
21. A phase II trial using thalidomide for Langerhans cell histiocytosis.
McClain KL; Kozinetz CA
Pediatr Blood Cancer; 2007 Jan; 48(1):44-9. PubMed ID: 16333818
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous Langerhans cell histiocytosis in children under one year.
Lau L; Krafchik B; Trebo MM; Weitzman S
Pediatr Blood Cancer; 2006 Jan; 46(1):66-71. PubMed ID: 16261594
[TBL] [Abstract][Full Text] [Related]
23. [Langerhans cell histiocytosis in childhood--results of the DAL-HX 83 study].
Gadner H; Heitger A; Ritter J; Göbel U; Janka GE; Kühl J; Bode U; Spaar HJ
Klin Padiatr; 1987; 199(3):173-82. PubMed ID: 3498085
[TBL] [Abstract][Full Text] [Related]
24. Langerhans cell histiocytosis in Turkish children.
Tokuç G; Boran P; Oktem S
Turk J Pediatr; 2009; 51(4):344-9. PubMed ID: 19950841
[TBL] [Abstract][Full Text] [Related]
25. Incidence of Langerhans cell histiocytosis in children: a population-based study.
Stålemark H; Laurencikas E; Karis J; Gavhed D; Fadeel B; Henter JI
Pediatr Blood Cancer; 2008 Jul; 51(1):76-81. PubMed ID: 18266220
[TBL] [Abstract][Full Text] [Related]
26. Histiocytic syndromes in children.
Cetingül N; Oztop S; Kavakli K; Ozunan I; Nişli G; Hekimgil M
Turk J Pediatr; 1997; 39(3):287-94. PubMed ID: 9339106
[TBL] [Abstract][Full Text] [Related]
27. Etoposide as the basic and interferon-alpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC.
Culić S; Jakobson A; Culić V; Kuzmić I; Sćukanec-Spoljar M; Primorac D
Pediatr Hematol Oncol; 2001 Jun; 18(4):291-4. PubMed ID: 11400655
[TBL] [Abstract][Full Text] [Related]
28. Langerhans' cell histiocytosis in adults: a clinical and therapeutic analysis of 11 patients from a single institution.
Giona F; Caruso R; Testi AM; Moleti ML; Malagnino F; Martelli M; Ruco L; Giannetti GP; Annibali S; Mandelli F
Cancer; 1997 Nov; 80(9):1786-91. PubMed ID: 9351548
[TBL] [Abstract][Full Text] [Related]
29. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H;
Med Pediatr Oncol; 2002 Dec; 39(6):581-5. PubMed ID: 12376981
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of langerhans cell histiocytosis in children].
Bilić E; Bojanić K; Pavlović M; Konja J; Femenić R; Dapić T; Antabak A; Anticević D; Murat-Susić S; Husar K; Potocki K; Rajić L
Lijec Vjesn; 2011; 133(11-12):376-84. PubMed ID: 22329293
[TBL] [Abstract][Full Text] [Related]
31. [Langerhans-cell histiocytosis (histiocytosis X); 20-year experience in the Emma Kinderziekenhuis, 1969-1988].
Egeler RM; de Kraker J; Voûte PA
Ned Tijdschr Geneeskd; 1993 May; 137(19):955-60. PubMed ID: 8497330
[TBL] [Abstract][Full Text] [Related]
32. Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China.
Su M; Gao YJ; Pan C; Chen J; Tang JY
Pediatr Hematol Oncol; 2018; 35(7-8):385-392. PubMed ID: 30693828
[TBL] [Abstract][Full Text] [Related]
33. Use of indomethacin in Langerhans cell histiocytosis.
Munn SE; Olliver L; Broadbent V; Pritchard J
Med Pediatr Oncol; 1999 Apr; 32(4):247-9. PubMed ID: 10102016
[TBL] [Abstract][Full Text] [Related]
34. [Langerhans-cell histiocytosis (histiocytosis X) in children].
Carstensen H; Ornvold K
Ugeskr Laeger; 1993 Jun; 155(23):1779-83. PubMed ID: 8317026
[TBL] [Abstract][Full Text] [Related]
35. Pattern and course of neurodegeneration in Langerhans cell histiocytosis.
Wnorowski M; Prosch H; Prayer D; Janssen G; Gadner H; Grois N
J Pediatr; 2008 Jul; 153(1):127-32. PubMed ID: 18571550
[TBL] [Abstract][Full Text] [Related]
36. Analysis of loss of heterozygosity in single-system and multisystem Langerhans' cell histiocytosis.
Chikwava KR; Hunt JL; Mantha GS; Murphy JE; Jaffe R
Pediatr Dev Pathol; 2007; 10(1):18-24. PubMed ID: 17378622
[TBL] [Abstract][Full Text] [Related]
37. Langerhans cell histiocytosis: retrospective analysis of 217 cases in a single center.
Yağci B; Varan A; Cağlar M; Söylemezoğlu F; Sungur A; Orhan D; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
Pediatr Hematol Oncol; 2008 Jun; 25(5):399-408. PubMed ID: 18569842
[TBL] [Abstract][Full Text] [Related]
38. Langerhans cell histiocytosis in children.
Grifo AH
J Pediatr Oncol Nurs; 2009; 26(1):41-7. PubMed ID: 18936291
[TBL] [Abstract][Full Text] [Related]
39. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of children younger than 24 months with langerhans cell histiocytosis and bone involvement: a report from a single institution.
Kamath S; Arkader A; Jubran RF
J Pediatr Orthop; 2014 Dec; 34(8):825-30. PubMed ID: 25387157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
